Brineura Interactions
No drug interactions were found for Brineura (cerliponase alfa). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Brineura (cerliponase alfa) is in the drug class lysosomal enzymes. Brineura (cerliponase alfa) is used for Neuronal Ceroid Lipofuscinosis.
Brineura disease interactions
There are 2 disease interactions with Brineura (cerliponase alfa) which include:
Report options
More about Brineura (cerliponase alfa)
- Brineura consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Aldurazyme
Aldurazyme is used to treat the symptoms of Hurler syndrome. Learn about side effects, interactions ...
Cerezyme
Cerezyme is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Elaprase
Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called ...
Elelyso
Elelyso (taliglucerase alfa) is used to treat Gaucher disease. Includes Elelyso side effects ...
Elfabrio
Elfabrio (pegunigalsidase alfa-iwxj) is an enzyme replacement treatment that may be used long-term ...
Fabrazyme
Fabrazyme (agalsidase beta) is used in the treatment of Fabry disease. Includes Fabrazyme side ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.